CARCINOMA, SQUAMOUS CELL
Clinical trials for CARCINOMA, SQUAMOUS CELL explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA, SQUAMOUS CELL trials appear
Sign up with your email to follow new studies for CARCINOMA, SQUAMOUS CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a Chemo-Immunotherapy cocktail spare head and neck cancer patients from radiation?
Disease control OngoingThis phase 2 trial tests a combination of two chemotherapy drugs (carboplatin and nab-paclitaxel) plus an immunotherapy drug (durvalumab) given before surgery for people with locally advanced head and neck cancer. The goal is to shrink or eliminate the tumor so that radiation—whi…
Matched conditions: CARCINOMA, SQUAMOUS CELL
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Weekly vs. Every-3-Week cisplatin: which is safer for head and neck cancer?
Disease control OngoingThis phase 2 trial tests whether giving cisplatin chemotherapy weekly alongside radiation causes fewer severe side effects than the standard every-3-week schedule in people with head and neck cancer. About 80 participants will receive one of the two schedules. The study also look…
Matched conditions: CARCINOMA, SQUAMOUS CELL
Phase: PHASE2 • Sponsor: Susanne Arnold • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Robotic surgery or radiation? new study compares which is better for throat cancer patients' quality of life
Symptom relief OngoingThis study compares two treatments for early-stage throat cancer: robotic surgery (TORS) or radiation therapy (IMRT). It looks at which one leads to better swallowing function and overall quality of life. About 138 adults with HPV-related throat cancer are taking part. The goal i…
Matched conditions: CARCINOMA, SQUAMOUS CELL
Phase: NA • Sponsor: Christian von Buchwald • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC